Glucose lowering efficacy of the aqueous stem bark extract of Trema orientalis (Linn) Blume in normal and streptozotocin diabetic rats

The glucose-lowering efficacy of the aqueous stem bark extract of Trema orientalis (Ulmaceae) was evaluated both in normal and streptozotocin-induced diabetic rats. In normoglycemic rats, the single oral administration of the aqueous extract of T. orientalis failed to reduce blood glucose levels whi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmazie 2006-03, Vol.61 (3), p.233-236
Hauptverfasser: Dimo, T., Ngueguim, F. T., Kamtchouing, P., Dongo, E., Tan, P. V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 236
container_issue 3
container_start_page 233
container_title Pharmazie
container_volume 61
creator Dimo, T.
Ngueguim, F. T.
Kamtchouing, P.
Dongo, E.
Tan, P. V.
description The glucose-lowering efficacy of the aqueous stem bark extract of Trema orientalis (Ulmaceae) was evaluated both in normal and streptozotocin-induced diabetic rats. In normoglycemic rats, the single oral administration of the aqueous extract of T. orientalis failed to reduce blood glucose levels while in STZ-diabetic rats, the plant extract (38-300 mg/kg) exhibited significant hypoglycaemic activity with a maximum effect of 29.67%, 5 hours after administration of the 75 mg/kg dose when compared with the diabetic untreated group. Glibenclamide was not able to lower blood glucose in STZ-diabetic rats, while it significantly lowered the blood sugar in normoglycemic rats. The hypoglycaemic property of T. orientalis was also assessed by an oral glucose tolerance test (OGTT) in STZ-diabetic rats. The aqueous extract of T. orientalis and the reference drug, glibenclamide, (10 mg/kg) produced significant blood glucose lowering effects in the diabetic rats when compared to the diabetic controls. One week after repeated administration of T. orientalis extract, blood glucose levels were significantly decreased (p < 0.05) and still remained low after 2 weeks (p < 0.01). The results indicated that T. orientalis stem bark extract significantly reduces blood glucose in STZ-induced diabetic rats by a mechanism different from that of sulfonylurea agents. The present investigation provides pharmacological evidence that the use of this plant extract in traditional medicine for cardiovascular disease can be of benefit particulary in diabetic patients.
format Article
fullrecord <record><control><sourceid>pubtec_pubme</sourceid><recordid>TN_cdi_pubmed_primary_16599266</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ingid>govi/pharmaz/2006/00000061/00000003/art00014</ingid><sourcerecordid>govi/pharmaz/2006/00000061/00000003/art00014</sourcerecordid><originalsourceid>FETCH-LOGICAL-i342t-df38d5d6f4fb72d9bc16676e23010a4aa157fab216252014f685e486f8185b473</originalsourceid><addsrcrecordid>eNp1kctOwzAQRbMAQXn8AvISFpVsx3GSJc-CVIkNrK1JMi4uiV1sB2g_gO_GpbBkNjPSXB3NvbOXTSjN2bRkQhxmRyEsKeWSy-ogO2SyqGsu5ST7mvVj6wKS3n2gN3ZBUGvTQrsmTpP4ggTeRnRjICHiQBrwrwQ_o4c2bgVPHgcgzhu0EXoTyPncWHtBrvpxQGIssc4P0BOwXQJ4XEW3cdG1adMZaDCalniI4STb19AHPP3tx9nz3e3T9f10_jh7uL6cT00ueJx2Oq-6opNa6KbkXd20TMpSIs8poyAAWFFqaDiTvOCUCS2rAkUldcWqohFlfpyd7birsRmwUytvBvBr9RdIEtzsBCmKrSe1dKO36SS1cO9GrV4g-dkoTqlU9Kck-x1orsDH1JlImMd_MKbdkba_2b5GvUtm8wTkjFYsV7QuatWhhrGPKoJXi40KifgNr4yNxw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Glucose lowering efficacy of the aqueous stem bark extract of Trema orientalis (Linn) Blume in normal and streptozotocin diabetic rats</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>IngentaConnect Free/Open Access Journals</source><creator>Dimo, T. ; Ngueguim, F. T. ; Kamtchouing, P. ; Dongo, E. ; Tan, P. V.</creator><creatorcontrib>Dimo, T. ; Ngueguim, F. T. ; Kamtchouing, P. ; Dongo, E. ; Tan, P. V.</creatorcontrib><description>The glucose-lowering efficacy of the aqueous stem bark extract of Trema orientalis (Ulmaceae) was evaluated both in normal and streptozotocin-induced diabetic rats. In normoglycemic rats, the single oral administration of the aqueous extract of T. orientalis failed to reduce blood glucose levels while in STZ-diabetic rats, the plant extract (38-300 mg/kg) exhibited significant hypoglycaemic activity with a maximum effect of 29.67%, 5 hours after administration of the 75 mg/kg dose when compared with the diabetic untreated group. Glibenclamide was not able to lower blood glucose in STZ-diabetic rats, while it significantly lowered the blood sugar in normoglycemic rats. The hypoglycaemic property of T. orientalis was also assessed by an oral glucose tolerance test (OGTT) in STZ-diabetic rats. The aqueous extract of T. orientalis and the reference drug, glibenclamide, (10 mg/kg) produced significant blood glucose lowering effects in the diabetic rats when compared to the diabetic controls. One week after repeated administration of T. orientalis extract, blood glucose levels were significantly decreased (p &lt; 0.05) and still remained low after 2 weeks (p &lt; 0.01). The results indicated that T. orientalis stem bark extract significantly reduces blood glucose in STZ-induced diabetic rats by a mechanism different from that of sulfonylurea agents. The present investigation provides pharmacological evidence that the use of this plant extract in traditional medicine for cardiovascular disease can be of benefit particulary in diabetic patients.</description><identifier>ISSN: 0031-7144</identifier><identifier>PMID: 16599266</identifier><language>eng</language><publisher>Germany: Govi-Verlag</publisher><subject>Animals ; Blood Glucose - metabolism ; Body Weight - drug effects ; Diabetes Mellitus, Experimental - blood ; Diabetes Mellitus, Experimental - drug therapy ; Diabetes Mellitus, Type 1 - blood ; Diabetes Mellitus, Type 1 - chemically induced ; Diabetes Mellitus, Type 1 - drug therapy ; Drinking - drug effects ; Eating - drug effects ; Glucose Tolerance Test ; Hypoglycemic Agents - pharmacology ; Hypoglycemic Agents - therapeutic use ; Male ; Plant Bark - chemistry ; Plant Extracts - pharmacology ; Rats ; Rats, Wistar ; Trema - chemistry</subject><ispartof>Pharmazie, 2006-03, Vol.61 (3), p.233-236</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>288,314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16599266$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dimo, T.</creatorcontrib><creatorcontrib>Ngueguim, F. T.</creatorcontrib><creatorcontrib>Kamtchouing, P.</creatorcontrib><creatorcontrib>Dongo, E.</creatorcontrib><creatorcontrib>Tan, P. V.</creatorcontrib><title>Glucose lowering efficacy of the aqueous stem bark extract of Trema orientalis (Linn) Blume in normal and streptozotocin diabetic rats</title><title>Pharmazie</title><addtitle>Pharmazie</addtitle><description>The glucose-lowering efficacy of the aqueous stem bark extract of Trema orientalis (Ulmaceae) was evaluated both in normal and streptozotocin-induced diabetic rats. In normoglycemic rats, the single oral administration of the aqueous extract of T. orientalis failed to reduce blood glucose levels while in STZ-diabetic rats, the plant extract (38-300 mg/kg) exhibited significant hypoglycaemic activity with a maximum effect of 29.67%, 5 hours after administration of the 75 mg/kg dose when compared with the diabetic untreated group. Glibenclamide was not able to lower blood glucose in STZ-diabetic rats, while it significantly lowered the blood sugar in normoglycemic rats. The hypoglycaemic property of T. orientalis was also assessed by an oral glucose tolerance test (OGTT) in STZ-diabetic rats. The aqueous extract of T. orientalis and the reference drug, glibenclamide, (10 mg/kg) produced significant blood glucose lowering effects in the diabetic rats when compared to the diabetic controls. One week after repeated administration of T. orientalis extract, blood glucose levels were significantly decreased (p &lt; 0.05) and still remained low after 2 weeks (p &lt; 0.01). The results indicated that T. orientalis stem bark extract significantly reduces blood glucose in STZ-induced diabetic rats by a mechanism different from that of sulfonylurea agents. The present investigation provides pharmacological evidence that the use of this plant extract in traditional medicine for cardiovascular disease can be of benefit particulary in diabetic patients.</description><subject>Animals</subject><subject>Blood Glucose - metabolism</subject><subject>Body Weight - drug effects</subject><subject>Diabetes Mellitus, Experimental - blood</subject><subject>Diabetes Mellitus, Experimental - drug therapy</subject><subject>Diabetes Mellitus, Type 1 - blood</subject><subject>Diabetes Mellitus, Type 1 - chemically induced</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Drinking - drug effects</subject><subject>Eating - drug effects</subject><subject>Glucose Tolerance Test</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Male</subject><subject>Plant Bark - chemistry</subject><subject>Plant Extracts - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Trema - chemistry</subject><issn>0031-7144</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctOwzAQRbMAQXn8AvISFpVsx3GSJc-CVIkNrK1JMi4uiV1sB2g_gO_GpbBkNjPSXB3NvbOXTSjN2bRkQhxmRyEsKeWSy-ogO2SyqGsu5ST7mvVj6wKS3n2gN3ZBUGvTQrsmTpP4ggTeRnRjICHiQBrwrwQ_o4c2bgVPHgcgzhu0EXoTyPncWHtBrvpxQGIssc4P0BOwXQJ4XEW3cdG1adMZaDCalniI4STb19AHPP3tx9nz3e3T9f10_jh7uL6cT00ueJx2Oq-6opNa6KbkXd20TMpSIs8poyAAWFFqaDiTvOCUCS2rAkUldcWqohFlfpyd7birsRmwUytvBvBr9RdIEtzsBCmKrSe1dKO36SS1cO9GrV4g-dkoTqlU9Kck-x1orsDH1JlImMd_MKbdkba_2b5GvUtm8wTkjFYsV7QuatWhhrGPKoJXi40KifgNr4yNxw</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>Dimo, T.</creator><creator>Ngueguim, F. T.</creator><creator>Kamtchouing, P.</creator><creator>Dongo, E.</creator><creator>Tan, P. V.</creator><general>Govi-Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20060301</creationdate><title>Glucose lowering efficacy of the aqueous stem bark extract of Trema orientalis (Linn) Blume in normal and streptozotocin diabetic rats</title><author>Dimo, T. ; Ngueguim, F. T. ; Kamtchouing, P. ; Dongo, E. ; Tan, P. V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i342t-df38d5d6f4fb72d9bc16676e23010a4aa157fab216252014f685e486f8185b473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Blood Glucose - metabolism</topic><topic>Body Weight - drug effects</topic><topic>Diabetes Mellitus, Experimental - blood</topic><topic>Diabetes Mellitus, Experimental - drug therapy</topic><topic>Diabetes Mellitus, Type 1 - blood</topic><topic>Diabetes Mellitus, Type 1 - chemically induced</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Drinking - drug effects</topic><topic>Eating - drug effects</topic><topic>Glucose Tolerance Test</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Male</topic><topic>Plant Bark - chemistry</topic><topic>Plant Extracts - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Trema - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dimo, T.</creatorcontrib><creatorcontrib>Ngueguim, F. T.</creatorcontrib><creatorcontrib>Kamtchouing, P.</creatorcontrib><creatorcontrib>Dongo, E.</creatorcontrib><creatorcontrib>Tan, P. V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Pharmazie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dimo, T.</au><au>Ngueguim, F. T.</au><au>Kamtchouing, P.</au><au>Dongo, E.</au><au>Tan, P. V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glucose lowering efficacy of the aqueous stem bark extract of Trema orientalis (Linn) Blume in normal and streptozotocin diabetic rats</atitle><jtitle>Pharmazie</jtitle><addtitle>Pharmazie</addtitle><date>2006-03-01</date><risdate>2006</risdate><volume>61</volume><issue>3</issue><spage>233</spage><epage>236</epage><pages>233-236</pages><issn>0031-7144</issn><abstract>The glucose-lowering efficacy of the aqueous stem bark extract of Trema orientalis (Ulmaceae) was evaluated both in normal and streptozotocin-induced diabetic rats. In normoglycemic rats, the single oral administration of the aqueous extract of T. orientalis failed to reduce blood glucose levels while in STZ-diabetic rats, the plant extract (38-300 mg/kg) exhibited significant hypoglycaemic activity with a maximum effect of 29.67%, 5 hours after administration of the 75 mg/kg dose when compared with the diabetic untreated group. Glibenclamide was not able to lower blood glucose in STZ-diabetic rats, while it significantly lowered the blood sugar in normoglycemic rats. The hypoglycaemic property of T. orientalis was also assessed by an oral glucose tolerance test (OGTT) in STZ-diabetic rats. The aqueous extract of T. orientalis and the reference drug, glibenclamide, (10 mg/kg) produced significant blood glucose lowering effects in the diabetic rats when compared to the diabetic controls. One week after repeated administration of T. orientalis extract, blood glucose levels were significantly decreased (p &lt; 0.05) and still remained low after 2 weeks (p &lt; 0.01). The results indicated that T. orientalis stem bark extract significantly reduces blood glucose in STZ-induced diabetic rats by a mechanism different from that of sulfonylurea agents. The present investigation provides pharmacological evidence that the use of this plant extract in traditional medicine for cardiovascular disease can be of benefit particulary in diabetic patients.</abstract><cop>Germany</cop><pub>Govi-Verlag</pub><pmid>16599266</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-7144
ispartof Pharmazie, 2006-03, Vol.61 (3), p.233-236
issn 0031-7144
language eng
recordid cdi_pubmed_primary_16599266
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; IngentaConnect Free/Open Access Journals
subjects Animals
Blood Glucose - metabolism
Body Weight - drug effects
Diabetes Mellitus, Experimental - blood
Diabetes Mellitus, Experimental - drug therapy
Diabetes Mellitus, Type 1 - blood
Diabetes Mellitus, Type 1 - chemically induced
Diabetes Mellitus, Type 1 - drug therapy
Drinking - drug effects
Eating - drug effects
Glucose Tolerance Test
Hypoglycemic Agents - pharmacology
Hypoglycemic Agents - therapeutic use
Male
Plant Bark - chemistry
Plant Extracts - pharmacology
Rats
Rats, Wistar
Trema - chemistry
title Glucose lowering efficacy of the aqueous stem bark extract of Trema orientalis (Linn) Blume in normal and streptozotocin diabetic rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T13%3A56%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubtec_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glucose%20lowering%20efficacy%20of%20the%20aqueous%20stem%20bark%20extract%20of%20Trema%20orientalis%20(Linn)%20Blume%20in%20normal%20and%20streptozotocin%20diabetic%20rats&rft.jtitle=Pharmazie&rft.au=Dimo,%20T.&rft.date=2006-03-01&rft.volume=61&rft.issue=3&rft.spage=233&rft.epage=236&rft.pages=233-236&rft.issn=0031-7144&rft_id=info:doi/&rft_dat=%3Cpubtec_pubme%3Egovi/pharmaz/2006/00000061/00000003/art00014%3C/pubtec_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16599266&rft_ingid=govi/pharmaz/2006/00000061/00000003/art00014&rfr_iscdi=true